Saudi Arabia healthcare markets

178 reports across 5 categories, with market size and growth to 2033.

Health in Saudi Arabia: WHO figures

Saudi Arabia: People and health spending

Companies most covered in Saudi Arabia

All 178 Saudi Arabia markets

Each market name opens its Saudi Arabia report. To compare one market across every country, see market statistics.

Digital Health 41 markets
Digital Health markets in Saudi Arabia
Market20232033 (projected)CAGR Active trials
3D Laparoscopy Imaging Systems $54 Mn $120 Mn 8.2% 0
3D Printed Implants $61 Mn $248 Mn 15% 0
3D Printing in Medical Application $41 Mn $293 Mn 21.8% 3
Artificial Intelligence (AI) in Drugs Discovery $10 Mn $117 Mn 27.6% 1
Artificial Intelligence (AI) in Healthcare – – – 5
Artificial Intelligence (AI) in Life Sciences $37 Mn $449 Mn 28.2% 4
Artificial Intelligence (AI) in Medical Imaging $15 Mn $163 Mn 26.7% 0
Artificial Intelligence (AI) in Medicine $141 Mn $3.8 Bn 39% 5
Artificial Intelligence (AI) in Pharma – – – 1
Artificial Intelligence (AI) in Radiology $10 Mn $142 Mn 30.1% 0
Artificial Intelligence (AI) in Remote Patient Monitoring $15 Mn $244 Mn 31.9% 1
Artificial Intelligence (AI) Machine Learning(ML) in Healthcare $32 Mn $902 Mn 39.5% 5
Blockchain in Genomics $38 Mn $1.1 Bn 39.8% 0
Blockchain-as-a-Service $36 Mn $522 Mn 30.8% 0
Brain Imaging, Biomarkers and NeuroInformatics $12 Mn $21 Mn 6.2% 15
Brain PET-MRI Systems $6 Mn $13 Mn 8% 9
Clinical Alarm Management $30 Mn $47 Mn 4.8% 2
Clinical Data Management Systems $43 Mn $150 Mn 13.4% 0
Connected Healthcare Market $1,000 Mn $12.4 Bn 28.6% 4
Decentralized Clinical Trials(DCTs) $28 Mn $126 Mn 16.3% 13
Dental 3D Printing $58 Mn $421 Mn 22% 2
Dental CAD/CAM $56 Mn $168 Mn 11.5% 0
Digital Biomarkers $75 Mn $1.7 Bn 37% 1
Digital diabetes care $218 Mn $1.4 Bn 20.8% 4
Digital Pathology Systems $20 Mn $84 Mn 15.2% 5
Digital Therapeutics $116 Mn $880 Mn 22.5% 16
Digital Twin $29 Mn $287 Mn 25.8% 1
Digital X-ray $296 Mn $598 Mn 7.3% 20
Electronic Health Record $614 Mn $1.1 Bn 5.7% 2
Healthcare Information System $4.9 Bn $27.2 Bn 18.6% 32
Healthcare IT $8.2 Bn $30.1 Bn 13.9% 7
Home Healthcare $6.2 Bn $15.1 Bn 9.4% 18
Internet Of Things In Healthcare $1.7 Bn $9.2 Bn 18.5% 0
IoT in Healthcare $3.1 Bn $16.9 Bn 18.6% 0
Long-term Care Software $60 Mn $223 Mn 14.1% 1
Mental Health Apps $95 Mn $707 Mn 22.2% 1
Pathology Imaging Systems $28 Mn $97 Mn 13.4% 5
Point of Care Diagnostics $772 Mn $1.8 Bn 8.9% 65
Remote Medication Management $66 Mn $360 Mn 18.5% 1
Remote Patient Monitoring $27 Mn $157 Mn 19.3% 3
Werable Healthcare Devices $555 Mn $3.8 Bn 21.3% 2
Healthcare Services 24 markets
Healthcare Services markets in Saudi Arabia
Market20232033 (projected)CAGR Active trials
Alopecia areata – – – 0
Alzheimers Dignostic $36 Mn $80 Mn 8.4% 2
Ambulance Service $532 Mn $1.2 Bn 8.6% 10
Ambulatory Surgery Center $680 Mn $1.4 Bn 7.6% 69
Antimicrobial Susceptibility Testing – – – 0
Bioinformatics $207 Mn $907 Mn 15.9% –
Biomaterial Wound Dressing $139 Mn $307 Mn 8.2% 0
Blood Gas and Electrolyte Analyzers $48 Mn $102 Mn 7.9% 5
Bone Cancer Diagnostic $19 Mn $44 Mn 8.9% 4
Brain Cancer Diagnostic $26 Mn $104 Mn 15.1% 4
Breast Cancer Diagnostic $70 Mn $170 Mn 9.3% 16
Clinical Laboratory Service – – – –
Dental Care Service – – – –
Dental Imaging $58 Mn $142 Mn 9.4% –
Dermatology Diagnostic $442 Mn $1.5 Bn 12.7% 15
Fertility Service $357 Mn $743 Mn 7.6% –
Healthcare Electronic Data Interchange (EDI) $68 Mn $191 Mn 10.9% 1
Healthcare In Vitro Diagnostic $1.4 Bn $2.4 Bn 5.3% 1
Hospitals and Health Systems $74.1 Bn $147.1 Bn 7.1% 227
Medical Billing $77 Mn $257 Mn 12.9% 0
Medical Tourism $1.3 Bn $4.6 Bn 13.7% 0
Nursing Education $175 Mn $438 Mn 9.6% 5
Patient Support Programs (PSP) $292 Mn $1.4 Bn 17.3% 7
Point Of Care (PoC) Molecular Diagnostic $318 Mn $887 Mn 10.8% 11
Medical Devices 27 markets
Medical Devices markets in Saudi Arabia
Market20232033 (projected)CAGR Active trials
Acute Care Needleless Connectors $8 Mn $20 Mn 9% –
Advanced Bipolar Direct Energy Devices $53 Mn $139 Mn 10.2% –
Aesthetic Lasers and Energy Devices $28 Mn $99 Mn 13.6% –
Air Ambulance Life Support Solutions $76 Mn $208 Mn 10.6% –
Airway Management Devices $34 Mn $65 Mn 6.7% –
Anastomosis Devices $54 Mn $119 Mn 8.3% –
Anesthesia & Respiratory Devices $488 Mn $1.4 Bn 11% –
Anesthesia Monitoring Devices $45 Mn $166 Mn 14% –
Angiography Devices $212 Mn $449 Mn 7.8% –
Angioplasty Balloons $69 Mn $116 Mn 5.3% –
Anti-Snoring Devices $21 Mn $57 Mn 10.3% –
Apheresis Equipments $43 Mn $91 Mn 7.7% –
Arrhythmia Monitoring Devices $102 Mn $201 Mn 7% –
Assisted Walking Aids $39 Mn $77 Mn 7% –
Audiology Devices $133 Mn $285 Mn 7.9% –
Defibrillator $301 Mn $616 Mn 7.4% –
Dental Articulators $7 Mn $14 Mn 7.9% –
Dental Caries Detectors $6 Mn $22 Mn 13.3% –
Dental Diagnostic and Surgical Equipments $204 Mn $465 Mn 8.6% –
Dental X-Ray Equipments $30 Mn $69 Mn 8.7% –
Diabetes Care Devices $724 Mn $1.5 Bn 7.4% –
Digital Diabetes Management – – – –
Direct Energy Medical Devices $188 Mn $352 Mn 6.5% –
Disposable Surgical Devices $154 Mn $357 Mn 8.8% –
Insulin Delivery Devices $270 Mn $583 Mn 8% –
Insulin Patch Pumps $15 Mn $54 Mn 13.5% –
Rehabilitation Equipments $340 Mn $708 Mn 7.6% –
OTC & Nutraceuticals 48 markets
OTC & Nutraceuticals markets in Saudi Arabia
Market20232033 (projected)CAGR Active trials
Adaptogens $138 Mn $357 Mn 10% –
Amino Acid – – – –
Anthelmintic Drug – – – –
Antioxidants – – – –
Antipyretics OTC – – – –
BCAA Supplement $24 Mn $52 Mn 8.2% –
Beauty Supplements $70 Mn $193 Mn 10.7% –
Biotin Supplement $7 Mn $13 Mn 6.5% –
Bone & Joint Health Supplements $204 Mn $436 Mn 7.9% –
Calcium Supplements $43 Mn $88 Mn 7.5% –
Cannabidiol (CBD) Supplements $90 Mn $484 Mn 18.3% –
Cardiovascular Health Supplements $116 Mn $232 Mn 7.2% –
Clinical Nutrition $485 Mn $1.1 Bn 8.6% –
Coenzyme Q10 $9 Mn $23 Mn 10.5% –
Collagen Supplements $37 Mn $78 Mn 7.6% –
Creatine $10 Mn $22 Mn 7.8% –
Dietary Supplements $5.2 Bn $11 Bn 7.7% –
Eye Health Supplements $53 Mn $111 Mn 7.7% –
Functional Food $4.8 Bn $10.7 Bn 8.2% –
Hair Growth Supplements $31 Mn $71 Mn 8.8% –
Herbal Supplements $1.4 Bn $3.3 Bn 9.1% –
Immune Health Supplement – – – –
Iron Supplement $34 Mn $73 Mn 8% –
Men's Health Supplements $308 Mn $683 Mn 8.3% –
Mood and Stress Supplements $179 Mn $446 Mn 9.6% –
Nutritional Supplements $6.5 Bn $14.5 Bn 8.3% –
Omega 3 Fatty Acid $70 Mn $164 Mn 8.9% –
Oncology Nutrition $36 Mn $83 Mn 8.8% –
Osteoporosis Supplements $53 Mn $114 Mn 8% –
Over The Counter (OTC) Analgesics $374 Mn $603 Mn 4.9% –
Over The Counter (OTC) Antifungal $43 Mn $71 Mn 5.3% –
Over The Counter (OTC) Consumer $2.6 Bn $4.9 Bn 6.7% –
Over The Counter (OTC) Drugs $3 Bn $5.5 Bn 6.2% –
Over The Counter (OTC) Gastrointestinal Drugs $95 Mn $161 Mn 5.4% –
Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs $247 Mn $425 Mn 5.6% –
Over The Counter (OTC) Ophthalmic Drugs $61 Mn $110 Mn 6% –
Over The Counter (OTC) Pharmaceuticals $3 Bn $5.5 Bn 6.2% –
Over The Counter (OTC) Sleep Aid Products $90 Mn $154 Mn 5.5% –
Over The Counter (OTC) Vitamins and Minerals $544 Mn $1.1 Bn 7% –
Plant-Based Supplements $209 Mn $518 Mn 9.5% –
Prebiotics $138 Mn $480 Mn 13.3% –
Probiotic Supplements for Gut Health $104 Mn $239 Mn 8.7% –
Protein Supplement $340 Mn $798 Mn 8.9% –
Sports Nutrition $884 Mn $2.2 Bn 9.4% –
Vitamin B12(Cobalamin) $5 Mn $10 Mn 7% –
Vitamin D Supplements – – – –
Weight Management Supplement – – – –
Women's Health Supplements $340 Mn $755 Mn 8.3% –
Pharmaceuticals 38 markets
Pharmaceuticals markets in Saudi Arabia
Market20232033 (projected)CAGR Active trials
Abuse Deterrent Opioids – – – –
Alexipharmic Drugs – – – –
Alopecia Drugs (Hair Loss) – – – –
Alzheimer Drugs $85 Mn $189 Mn 8.3% –
Aminoglycosides – – – –
Anemia Drugs – – – –
Anti-Aging $1.5 Bn $3.7 Bn 9.6% –
Anti-Depressants Drugs $306 Mn $462 Mn 4.2% –
Anti-Nerve Growth Factor – – – –
Anti-Venom – – – –
Anticoagulants – – – –
Antithrombotic Drugs – – – –
Artificial Skin $43 Mn $86 Mn 7.3% –
Asthma & COPD Drugs $842 Mn $1.4 Bn 5.5% –
Atherosclerosis Drugs – – – –
Atopic Dermatitis Drugs $191 Mn $689 Mn 13.7% –
Autologous Matrix-induced Chondrogenesis – – – –
Axial Spondyloarthritis (axSpA) – – – –
Biological Safety Testing – – – –
Biosimilar Monoclonal Antibodies – – – –
Biosimilars $627 Mn $6.5 Bn 26.4% –
Blood Plasma – – – –
Bone Marrow Aspirate Concentrates – – – –
Burn Care – – – –
Burn Ointment – – – –
Cancer Supportive Care Drugs $422 Mn $769 Mn 6.2% –
Cannabidiol (CBD) $375 Mn $2 Bn 18.3% –
Cannabis $576 Mn $2.3 Bn 15% –
Cell Based Immunotherapy $282 Mn $2.5 Bn 24.5% –
Contraceptives Drugs $428 Mn $951 Mn 8.3% –
Cord Blood Banking Service $32 Mn $70 Mn 8% –
Diabetes Management $1.3 Bn $3 Bn 8.6% –
Diabetic Retinopathy Drugs $184 Mn $378 Mn 7.5% –
Epilepsy Drugs $163 Mn $266 Mn 5% –
Gastroesophageal Reflux Disease (GERD) Drugs $88 Mn $126 Mn 3.6% –
Gastrointestinal Drugs $918 Mn $1.7 Bn 6.1% –
HIV Drugs $510 Mn $1 Bn 7.3% –
Oncology/Cancer Drugs $3 Bn $7.7 Bn 9.9% –

"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.

Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.

All 178 Saudi Arabia reports Other countries